Literature DB >> 837498

Alternans of the ST segment in Prinzmetal's angina.

M J Kleinfeld, J J Rozanski.   

Abstract

Alternans of the elevated ST segment (STEA) was found in 8 of 21 patients (38%) with Prinzmetal's variant angina. In addition to STEA, all eight patients had varying cardiac arrhythmias: multiple premature ventricular depolarizations in eight, ventricular tachycardia in five, and ventricular fibrillation in three. There was no consistent temporal relationship between the occurrence of STEA and the cardiac arrhythmias. Alternans occurred during periods when no arrhythmias were present. All eight patients underwent coronary angiography. Spontaneous coronary artery spasm was documented angiographically in three patients including two who had minimal or no coronary atherosclerotic disease. Six patients had severe, fixed, occlusive coronary artery disease. Possible mechanisms for STEA include: 1) failure of regions of myocardium to depolarize on alternate beats due to variation in conduction and refractoriness between ischemic and nonischemic zones of myocardium, and 2) electrical alternans of the transmembrane action potential during phase 2 and 3 (repolarization) caused by changes in the rate and extent of electrolyte transfer across cell membranes during ischemia. It is postulated that STEA is an electrocardiographic sign in the surface ECG of a dysequilibrium of refractory periods during ischemia and reflects an unstable electrical state of the myocardium.

Entities:  

Mesh:

Year:  1977        PMID: 837498     DOI: 10.1161/01.cir.55.4.574

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

1.  Unusual case of exercise-induced ST segment elevation alternans: successful treatment with transluminal coronary angioplasty.

Authors:  G Mammen; Z Krajcer; R D Leachman
Journal:  Tex Heart Inst J       Date:  1983-06

2.  Novel algorithm for identifying T-wave current density alternans using synthesized 187-channel vector-projected body surface mapping.

Authors:  Kenji Nakai; Shin Takahashi; Atsushi Suzuki; Nobuhisa Hagiwara; Keisuke Futagawa; Morio Shoda; Tsuyoshi Shiga; Ken Takahashi; Hitoshi Okabayashi; Manabu Itoh; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2010-10-30       Impact factor: 2.037

Review 3.  T-wave alternans testing for ventricular arrhythmias.

Authors:  Sanjiv M Narayan
Journal:  Prog Cardiovasc Dis       Date:  2008 Sep-Oct       Impact factor: 8.194

4.  Microvolt T-wave alternans during Holter monitoring in children and adolescents.

Authors:  Leonid Makarov; Vera Komoliatova
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

5.  Effects of bepridil and lidocaine on the intraventricular conduction in acutely ischaemic and infarcted canine myocardium.

Authors:  H Hashimoto; N Satoh; M Nakashima
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

Review 6.  Noninvasive sudden death risk stratification by ambulatory ECG-based T-wave alternans analysis: evidence and methodological guidelines.

Authors:  Richard L Verrier; Bruce D Nearing; Kevin F Kwaku
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-01       Impact factor: 1.468

7.  Microvolt-level T-wave alternans determination using the spectral method in patients with QT prolongation: value of adjusting the T-wave window.

Authors:  Elizabeth S Kaufman; Steven A Lewis; Peter Leo; Ganesh Aswath; Ohad Ziv; Lahn Fendelander
Journal:  J Electrocardiol       Date:  2012-09-07       Impact factor: 1.438

8.  Effects of calcium antagonists on the alternation of the ST-T complex and associated conduction abnormalities during coronary occlusion in dogs.

Authors:  H Hashimoto; M Nakashima
Journal:  Br J Pharmacol       Date:  1981-10       Impact factor: 8.739

9.  T wave alternans and ventricular tachyarrhythmia risk stratification: a review.

Authors:  Masahiko Takagi; Junichi Yoshikawa
Journal:  Indian Pacing Electrophysiol J       Date:  2003-04-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.